Janux Therapeutics, Inc. (JANX) SEC Filings — 2024
34 SEC filings for Janux Therapeutics, Inc. (JANX) in 2024.
Filings
- Janux Therapeutics Files 8-K — 8-K · Dec 5, 2024
- Janux Therapeutics Files 8-K — 8-K · Dec 2, 2024
- Janux Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Janux Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Janux Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Janux Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Avalon Ventures XI Amends Janux Therapeutics Stake — SC 13D/A · Nov 8, 2024
- Janux Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 6, 2024
- Janux Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Avalon Ventures XI Amends Janux Therapeutics Stake — SC 13D/A · Oct 25, 2024
- Janux Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 23, 2024
- Avalon Ventures XI Updates Janux Therapeutics Stake — SC 13D/A · Oct 22, 2024
- RA Capital Amends Janux Therapeutics Filing — SC 13D/A · Sep 16, 2024
- OrbiMed Amends Janux Therapeutics Stake Filing — SC 13D/A · Aug 9, 2024
- Janux Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
- Janux Therapeutics Appoints New CMO and CDO — 8-K · Jul 22, 2024
- Janux Therapeutics Files 8-K on Security Holder Vote Matters — 8-K · Jun 28, 2024
- Janux Therapeutics Files Proxy Supplement — DEFA14A · Jun 17, 2024
- Avalon Ventures Adjusts Janux Therapeutics Stake — SC 13D/A · Jun 5, 2024
- Janux Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
- Janux Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 29, 2024
- Janux Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 8, 2024
- RA Capital Amends Janux Therapeutics Stake Filing — SC 13D/A · Mar 6, 2024
- Avalon Ventures XI Adjusts Janux Therapeutics Stake — SC 13D/A · Mar 4, 2024
- Janux Therapeutics Files 8-K Report — 8-K · Feb 29, 2024
- Janux Therapeutics Files Routine 8-K — 8-K · Feb 28, 2024
- Janux Therapeutics Files Generic 8-K for 'Other Event' — 8-K · Feb 27, 2024
- Janux Therapeutics Files 8-K for Regulation FD Disclosure — 8-K · Feb 26, 2024
- Janux Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Janux Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Janux Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Janux Therapeutics Insider Dr. David Campbell Holds 7.0% Stake — SC 13G/A · Feb 9, 2024
- FMR LLC & Abigail Johnson Maintain 10.117% Stake in Janux Therapeutics — SC 13G/A · Feb 9, 2024
- Bregua Corp. Maintains Significant Stake in Janux Therapeutics — SC 13G/A · Feb 1, 2024